Cargando…
Precision medicine for adjuvant chemotherapy of resected colorectal cancer
Colorectal cancer (CRC) is the most common cancer and the second leading cause of cancer death in Japan. Surgical resection is the only curative option for localized disease. However, undetectable micrometastases remaining after curative surgery may cause disease recurrence. Adjuvant chemotherapy ai...
Autores principales: | Miyamoto, Yuji, Hiyoshi, Yukiharu, Sawayama, Hiroshi, Tokunaga, Ryuma, Baba, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726679/ https://www.ncbi.nlm.nih.gov/pubmed/33319153 http://dx.doi.org/10.1002/ags3.12397 |
Ejemplares similares
-
Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022) -
Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022) -
The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
por: Horino, Taichi, et al.
Publicado: (2021) -
Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
por: Miyamoto, Yuji, et al.
Publicado: (2015) -
Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
por: Matsuishi, Kozue, et al.
Publicado: (2020)